Cargando…
A New Model for Providing Cell-Free DNA and Risk Assessment for Chromosome Abnormalities in a Public Hospital Setting
Objective. Cell-free DNA (cfDNA) offers highly accurate noninvasive screening for Down syndrome. Incorporating it into routine care is complicated. We present our experience implementing a novel program for cfDNA screening, emphasizing patient education, genetic counseling, and resource management....
Autores principales: | Wallerstein, Robert, Jelks, Andrea, Garabedian, Matthew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102090/ https://www.ncbi.nlm.nih.gov/pubmed/25101177 http://dx.doi.org/10.1155/2014/962720 |
Ejemplares similares
-
Complete uniparental disomy of chromosome 1 in a child with isolated developmental delay
por: Wallerstein, Violet, et al.
Publicado: (2022) -
Prenatal Diagnosis of Cystic Hygroma related to a Deletion of 16q24.1 with Haploinsufficiency of FOXF1 and FOXC2 Genes
por: Garabedian, Matthew J., et al.
Publicado: (2012) -
Reliability of Cell-Free DNA and Targeted NGS in Predicting Chromosomal Abnormalities of Patients With Myeloid Neoplasms
por: Ip, Andrew, et al.
Publicado: (2022) -
Investigating the “Fetal Side” in Recurrent Pregnancy Loss: Reliability of Cell-Free DNA Testing in Detecting Chromosomal Abnormalities of Miscarriage Tissue
por: D’Ippolito, Silvia, et al.
Publicado: (2023) -
Cell-Free DNA Screening for Sex Chromosome Abnormalities and Pregnancy Outcomes, 2018–2020: A Retrospective Analysis
por: Lu, Yanmei, et al.
Publicado: (2022)